Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Form 8.3 - EXO LN

30 May 2017 07:00

RNS Number : 4705G
Syquant Capital
30 May 2017
Β 

Table

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Exova Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

26th May 2017

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

1p ordinary

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Derivatives (other than options):

2,913,300

1.17

(3) Options and agreements to purchase/sell:

TOTAL:

2,913,300

1.17

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

Β 

Β 

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

Increasing a long position

17,500

237.5 GBp

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

29th May 2017

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETOKCDNPBKDPPB
Date   Source Headline
19th Dec 20143:30 pmRNSDirector/PDMR Shareholding
16th Dec 20144:40 pmRNSSecond Price Monitoring Extn
16th Dec 20144:35 pmRNSPrice Monitoring Extension
12th Dec 20144:40 pmRNSSecond Price Monitoring Extn
12th Dec 20144:35 pmRNSPrice Monitoring Extension
10th Dec 201410:00 amRNSManagement Change
20th Nov 20143:40 pmRNSDirector/PDMR Shareholding
19th Nov 20144:30 pmRNSTR-1: Notification of Major Interest in Shares
19th Nov 20147:00 amRNSTrading Update
4th Nov 20144:40 pmRNSSecond Price Monitoring Extn
4th Nov 20144:35 pmRNSPrice Monitoring Extension
30th Oct 20144:35 pmRNSPrice Monitoring Extension
27th Oct 20144:40 pmRNSSecond Price Monitoring Extn
27th Oct 20144:35 pmRNSPrice Monitoring Extension
21st Oct 20143:11 pmRNSTR-1: Notification of Major Interest in Shares
17th Oct 20144:40 pmRNSSecond Price Monitoring Extn
17th Oct 20144:35 pmRNSPrice Monitoring Extension
13th Oct 20144:35 pmRNSPrice Monitoring Extension
3rd Oct 20149:40 amRNSHolding(s) in Company
1st Oct 20143:30 pmRNSTotal Voting Rights
30th Sep 20149:26 amRNSNotification of transaction of PDMRs
11th Sep 20149:10 amRNSHolding(s) in Company
4th Sep 20145:15 pmRNSIssue of Equity
4th Sep 201411:10 amRNSDirector/PDMR Shareholding
3rd Sep 20141:45 pmRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNS2014 Half Year Results
21st Jul 20148:00 amRNSAcquisition
30th Jun 20147:00 amRNSAnalyst Site Visit
3rd Jun 201410:08 amRNSDirector/PDMR Shareholding
3rd Jun 201410:03 amRNSAppointment of Joint Corporate Brokers
28th May 201411:18 amRNSNotification of new directorship
19th May 20147:00 amRNSInterim Management Statement
15th May 20141:52 pmRNSTR-1: Notification of major interest in shares
12th May 20144:14 pmRNSTR-1: Notification of major interest in shares
9th May 20145:00 pmRNSExova Group PLC - End of Stabilisation Notice
9th May 20144:54 pmRNSExercise of Over-allotment Option
28th Apr 20143:15 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20149:30 amRNSDirector/PDMR Shareholding
22nd Apr 20149:30 amRNSTR-1: Notification of major interest in shares
22nd Apr 20149:30 amRNSTR-1: Notification of major interest in shares
16th Apr 20148:24 amRNSDirector Declaration
16th Apr 20148:01 amRNSAdmission to Listing on LSE
11th Apr 201412:27 pmRNSPublication of Prospectus
11th Apr 20147:01 amRNSStabilisation Notice
11th Apr 20147:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.